🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare the incremental area under the curve from...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-05-20
Trial ID
NCT02428699
Treatments Being Tested
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
The primary goal of this study is to provide a better understanding of: 1) ...
Status
Completed
Location
Washington University School of Medicine
Start Date
2004-10
Trial ID
NCT00262964
Treatments Being Tested
Children with diabetic ketoacidosis risk neurological complications such as...
Status
Completed
Location
University hospital Montpellier
Start Date
2016-10-03
Trial ID
NCT02994316
Treatments Being Tested
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
The purpose of this study is to examine the pattern of plasma amino acid ap...
Status
Completed
Location
Lindenwood University
Start Date
2020-11-20
Trial ID
NCT05313178
Treatments Being Tested
Rhesus conflict between mother and fetus is due to the different antigenic ...
Status
Unknown
Location
Municipal non-profit enterprise "Cherkasy Regional Hospital of Cherkasy Regional Council"
Start Date
2022-02-08
Trial ID
NCT05245734
Treatments Being Tested
Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with ...
Status
Active Not Recruiting
Location
Cellectar Biosciences site
Start Date
2017-07-26
Trial ID
NCT02952508
Treatments Being Tested
Hospital-acquired infections, most of which are caused by Gram-negative bac...
Status
Not Yet Recruiting
Location
CHU GRENOBLE, Médecine intensive
Start Date
2026-01
Trial ID
NCT07085624
Treatments Being Tested
Ceftobiprole, a fifth-generation cephalosporin, exhibits potent antibacteri...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-12
Trial ID
NCT07127185
Treatments Being Tested